Dysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupus

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Sang, Allison ^a   Zheng, Ying Yi ^a   Yin, Yiming ^a   Dozmorov, Igor ^b   Li, Hao ^c   Hsu, Hui Chen ^c   Mountz, John D ^c   Morel, Laurence ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 6; PRISTANE; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW CELL; CELL EXPANSION; CELL INTERACTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHROMATIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CONGENIC STRAIN; DISEASE MODEL; DRUG EFFECTS; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, CONGENIC; MICE, INBRED C57BL;

EID: 84905707121     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102151     Document Type: Article

References (62)

1. Jego G, Pascual V, Palucka AK, Banchereau J (2005) Dendritic cells control B cell growth and differentiation. Curr Dir Autoimmun 8: 124-139.
2. Morel L, Croker BP, Blenman KR, Mohan C, Huang G, et al. (2000) Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA 97: 6670-6675. (Pubitemid 30412772)
3. Wan S, Zhou Z, Duan B, Morel L (2008) Direct B cell stimulation by dendritic cells in a mouse model of lupus. Arthritis Rheum 58: 1741-1750. (Pubitemid 351847528)
4. Cassese G, Arce S, Hauser AE, Lehnert K, Moewes B, et al. (2003) Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol 171: 1684-1690. (Pubitemid 36966450)
5. Hirano T, Kishimoto T (1989) Interleukin 6 and plasma cell neoplasias. Prog Growth Factor Res 1: 133-142.
6. Esposito P, Balletta MM, Procino A, Postiglione L, Memoli B (2009) Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis. Lupus 18: 1329-1330.
7. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, et al. (1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147: 117-123.
8. Finck BK, Chan B, Wofsy D (1994) Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest 94: 585-591. (Pubitemid 24250987)
9. Mihara M, Takagi N, Takeda Y, Ohsugi Y (1998) IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice. Clin Exp Immunol 112: 397-402. (Pubitemid 28267419)
10. Lande R, Gilliet M (2010) Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann N Y Acad Sci 1183: 89-103.
11. Kiefer K, Oropallo MA, Cancro MP, Marshak-Rothstein A (2012) Role of type I interferons in the activation of autoreactive B cells. Immunol Cell Biol 90: 498-504.
12. Elkon KB, Wiedeman A (2012) Type I IFN system in the development and manifestations of SLE. Curr Opin Rheumatol 24: 499-505.
13. Sriram U, Varghese L, Bennett HL, Jog NR, Shivers DK, et al. (2012) Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset. J Immunol 189: 80-91.
14. Teichmann LL, Ols ML, Kashgarian M, Reizis B, Kaplan DH, et al. (2010) Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity 33: 967-978.
15. Ganguly D, Haak S, Sisirak V, Reizis B (2013) The role of dendritic cells in autoimmunity. Nat Rev Immunol 13: 566-577.
16. Gerl V, Lischka A, Panne D, Grossmann P, Berthold R, et al. (2010) Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function. Ann Rheum Dis 69: 1370-1377.
17. Kaneko T, Saito Y, Kotani T, Okazawa H, Iwamura H, et al. (2012) Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and induces autoimmunity. J Immunol 188: 5397-5407.
18. Morel L, Croker BP, Blenman KR, Mohan C, Huang G, et al. (2000) Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci U S A 97: 6670-6675. (Pubitemid 30412772)
19. Herlands R, William J, Hershberg U, Shlomchik M (2007) Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. Eur J Immunol 37: 3339-3351.
20. Hannum LG, Ni D, Haberman AM, Weigert MG, Shlomchik MJ (1996) A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J Exp Med 184: 1269-1278. (Pubitemid 26354682)
21. Xu Z, Vallurupalli A, Fuhrman C, Ostrov D, Morel L (2011) An NZB-derived locus suppresses chronic graft versus host disease and autoantibody production through non-lymphoid bone-marrow derived cells. J Immunol 186: 4130-4139.
22. Lantow M, Sivakumar R, Zeumer L, Wasserfall C, Zheng YY, et al. (2013) The granulocyte colony stimulating factor pathway regulates autoantibody production in a murine induced model of systemic lupus erythematosus. Arthritis Res Ther 15: R49.
23. Cuda CM, Li S, Liang S, Yin Y, Potula HH, et al. (2012) Pre-B cell leukemia homeobox 1 is associated with lupus susceptibility in mice and humans. J Immunol 188: 604-614.
24. Brawand P, Fitzpatrick DR, Greenfield BW, Brasel K, Maliszewski CR, et al. (2002) Murine plasmacytoid pre-dendritic cells generated from Flt3 ligandsupplemented bone marrow cultures are immature APCs. J Immunol 169: 6711-6719. (Pubitemid 36899255)
25. Wan S, Xia C, Morel L (2007) IL-6 produced by dendritic cells from lupusprone mice inhibits CD4+CD25+ T cell regulatory functions. J Immunol 178: 271-279. (Pubitemid 46033610)
26. Ramanujam M, Bethunaickan R, Huang W, Tao H, Madaio M, et al. (2010) Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice. Arthritis Rheum 62: 1457-1468.
27. Kim SJ, Zou YR, Goldstein J, Reizis B, Diamond B (2011) Tolerogenic function of Blimp-1 in dendritic cells. J Exp Med 208: 2193-2199.
28. Vremec D, O'Keeffe M, Hochrein H, Fuchsberger M, Caminschi I, et al. (2007) Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. Blood 109: 1165-1173. (Pubitemid 46220664)
29. Kimura A, Kishimoto T (2010) IL-6: Regulator of Treg/Th17 balance. Eur J Immunol 40: 1830-1835.
30. Bermejo DA, Jackson SW, Gorosito-Serran M, Acosta-Rodriguez EV, Amezcua-Vesely MC, et al. (2013) Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors ROR[gamma]t and Ahr that leads to IL-17 production by activated B cells. Nat Immunol 14: 514-522.
31. Dubois B, Massacrier C, Vanbervliet B, Fayette J, Briere F, et al. (1998) Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J Immunol 161: 2223-2231. (Pubitemid 28397033)
32. G J, AK P, JP B, C C, V P, et al. (2003) Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19: 225.
33. Satpathy AT, Wu X, Albring JC, Murphy KM (2012) Re(de)fining the dendritic cell lineage. Nat Immunol 13: 1145-1154.
34. Merad M, Sathe P, Helft J, Miller J, Mortha A (2013) The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31: 563-604.
35. Chappell CP, Draves KE, Giltiay NV, Clark EA (2012) Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses. J Exp Med 209: 1825-1840.
36. Boulé M, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, et al. (2004) Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 199: 1631-1640. (Pubitemid 38821996)
37. Marshak-Rothstein A, Rifkin IR (2007) Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 25: 419-441. (Pubitemid 46697913)
38. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, et al. (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863-869. (Pubitemid 32983021)
39. Losman MJ, Fasy TM, Novick KE, Monestier M (1992) Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. The J Immunol 148: 1561-1569.
40. Miles K, Heaney J, Sibinska Z, Salter D, Savill J, et al. (2012) A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A 109: 887-892.
41. Petri M, Stohl W, Chatham W, McCune WJ, Chevrier M, et al. (2008) Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum 58: 2453-2459.
42. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, et al. (2009) A largescale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41: 1228-1233.
43. Chan YH, Chiang MF, Tsai YC, Su ST, Chen MH, et al. (2009) Absence of the transcriptional repressor Blimp-1 in hematopoietic lineages reveals its role in dendritic cell homeostatic development and function. J Immunol 183: 7039-7046.
44. Asselin-Paturel C, Brizard G, Chemin K, Boonstra A, O'Garra A, et al. (2005) Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 201: 1157-1167. (Pubitemid 40528442)
45. Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli AE, Denkers EY (2008) Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J Immunol 181: 8485-8491.
46. Kutzner H, Kerl H, Pfaltz MC, Kempf W (2009) CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications. Am J Surg Pathol 33: 1307-1313.
47. Wang JH, Li J, Wu Q, Yang P, Pawar RD, et al. (2010) Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity. J Immunol 184: 442-451.
48. Wang JH, Wu Q, Yang P, Li H, Li J, et al. (2011) Type I interferon-dependent CD86(high) marginal zone precursor B cells are potent T cell costimulators in mice. Arthritis Rheum 63: 1054-1064.
49. Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, et al. (2005) Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434: 1035-1040. (Pubitemid 40586053)
50. Negishi H, Ohba Y, Yanai H, Takaoka A, Honma K, et al. (2005) Negative regulation of Toll-like-receptor signaling by IRF-4. Proc Natl Acad Sci U S A 102: 15989-15994. (Pubitemid 41552855)
51. Hou B, Reizis B, DeFranco AL (2008) Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity 29: 272-282.
52. Teichmann LL, Schenten D, Medzhitov R, Kashgarian M, Shlomchik MJ (2013) Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity 38: 528-540.
53. Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, et al. (2005) Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 115: 407-417. (Pubitemid 40385482)
54. Hofmann SR, Rösen-Wolff A, Tsokos GC, Hedrich CM (2012) Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clin Immunol 143: 116-127.
55. Wang B, Zhu J-M, Fan Y-G, Xu W-D, Cen H, et al. (2013) Association of the - 1082G/A polymorphism in the interleukin-10 gene with systemic lupus erythematosus: A meta-analysis. Gene 519: 209-216.
56. Liu P, Song J, Su H, Li L, Lu N, et al. (2013) IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis. PLoS One 8: e69547.
57. Sakurai D, Zhao J, Deng Y, Kelly JA, Brown EE, et al. (2013) Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression. PLoS Genet 9: e1003870.
58. Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, et al. (2006) IL-10 regulation of lupus in the NZM2410 murine model. Lab Invest 86: 1136-1148. (Pubitemid 44624150)
59. Mauri C, Blair PA (2010) Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol 6: 636-643.
60. Xiao S, Brooks CR, Zhu C, Wu C, Sweere JM, et al. (2012) Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc Natl Acad Sci U S A 109: 12105- 12110.
61. Ling G-S, Cook HT, Botto M, Lau Y-L, Huang F-P (2011) An essential protective role of IL-10 in the immunological mechanism underlying resistance vs susceptibility to lupus induction by dendritic cells and dying cells. Rheumatology 50: 1773-1784.
62. Mohan C, Alas E, Morel L, Yang P, Wakeland E (1998) Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J Clin Invest 101: 1362-1372. (Pubitemid 28145253)